28. HEMODYNAMIC MONITORING DEVICES - % GROWTH RATE FORECASTS FOR CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS - (2012-2018)
C. INVESTMENT FOCUS
29. HEMODYNAMIC MONITORING DEVICES - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
30. HEMODYNAMIC MONITORING DEVICES - CARDIAC OUTPUT MONITORING DEVICES AND PULMONARY ARTERY CATHETERS - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 - Market Analysis Description
Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 - Market Analysis
BRICSS (Brazil, Russia, India, China, South Africa and South Korea) Hemodynamic Monitoring Devices sector to worth US$281 million by 2016, growing at a CAGR of 27.4% during 2012-2018
Global Market Watch:
BRICSS Hemodynamic Monitoring Devices market value is expected to reach US$281 million by 2016, primarily supported by the product types - Cardiac Output Monitoring Devices and Pulmonary Artery Catheters. China accounts for nearly 24% of the market share and India claims more than 24%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Cardiac Output Monitoring Devices market value indicates more than 60% by 2015 leaving the rest of the market to the Pulmonary Artery Catheters.
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
The report ‘Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations. The report primarily focuses on:
Emerging Market Trends
Advancements in the Technological Space
Market Demand of The Segments (By-Region)
Key Growth Areas and Market Size
Region-Wise Demand Factor
Key Competitors Edge
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with by type. Further, the subdivided categories include:
Hemodynamic Monitoring Devices – By Type
a. Cardiac Output Monitoring Devices (Minimally Invasive and Non-Invasive Devices)
b. Pulmonary Artery Catheters (Invasive)
The period considered for the hemodynamic monitoring devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil, Russia, India, China, South Korea and South Africa).
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 105 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.
INTERFACE BIOLOGICS, INC.
MERIDIAN HEALTH SYSTEM, INC
CARDIVA MEDICAL, INC.
LOMBARD MEDICAL TECHNOLOGIES PLC
DELTEX MEDICAL GROUP PLC
ASAHI INTECC CO., LTD.
MERIT MEDICAL SYSTEMS, INC.
MOLECULAR DEVICES, LLC
ABBOTT VASCULAR DEVICES
CAMBRIDGE HEART, INC.
ADVANSOURCE BIOMATERIALS CORPORATION
ATRIUM MEDICAL CORPORATION
BIOPHAN TECHNOLOGIES, INC.
BIOSENSE WEBSTER, INC.
BOSTON SCIENTIFIC CORPORATION
CARDIAC SCIENCE CORPORATION
COOK GROUP INCORPORATED
MAQUET GMBH & CO. KG
EDWARDS LIFESCIENCES, LLC.
ISSYS SENSING SYSTEMS, INC
APTUS ENDOSYSTEMS, INC.
JOHNSON & JOHNSON
MILLAR INSTRUMENTS, INC
MONEBO TECHNOLOGIES, INC.
MORTARA INSTRUMENT, INC.
SIEMENS MEDICAL SOLUTIONS USA, INC.
SORIN GROUP USA, INC.
ST. JUDE MEDICAL
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
TERUMO HEART, INC.
VICOR TECHNOLOGIES, INC.
PULSION MEDICAL SYSTEMS SE
BAXTER INTERNATIONAL INC.
BECTON, DICKINSON & CO.
NOVADAQ TECHNOLOGIES INC.
SCOTTCARE CARDIOVASCULAR SOLUTIONS
VARIAN MEDICAL SYSTEMS, INC.
SUNSHINE HEART, INC.
ASH ACCESS TECHNOLOGY, INC.
C. R. BARD, INC.
SURGICAL SPECIALISTIES CORPORATION
CARDIUM THERAPEUTICS, INC.
CARDIOCOMM SOLUTIONS, INC.
BERLIN HEART GMBH
SOPHION BIOSCIENCE A/S
BIOTRONIK GMBH & CO. KG.
DRÄGER MEDICAL AG & CO. KG
SPECTRANETICS INTERNATIONAL B.V
AORTECH INTERNATIONAL, PLC.
APC CARDIOVASCULAR, LTD.
ARTERIAL REMODELING TECHNOLOGIES
LIDCO GROUP PLC
PHILIPS MEDICAL SYSTEMS
SMITH & NEPHEW PLC
FLEMING MEDICAL LIMITED
NIHON KOHDEN CORPORATION
ALL PRO CORPORATION
FUKUDA DENSHI CO., LTD.
SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD